Nevi and lasers: Practical considerations

Tova Rogers1, Andrew C Krakowski2, Maria L Marino1

  • 1Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Insights

Laser ablation of melanocytic nevi (MN) carries debated risks, including misdiagnosis and incomplete removal. This study offers practical suggestions to mitigate risks and enhance patient outcomes for laser MN treatment.

Area of Science:

  • Dermatology
  • Laser Medicine
  • Oncology

Background:

  • Elective laser ablation for melanocytic nevi (MN) is increasing.
  • Risks associated with laser MN treatment are not well-studied.

Discussion:

  • Theoretical risks include misdiagnosing melanoma as nevus, incomplete nevus cell removal, and potential malignant transformation of residual cells.
  • Challenges in monitoring residual nevi for melanoma progression and assessing lesion suitability for laser removal are significant.
  • Managing patient expectations regarding variable cosmetic outcomes is crucial.

Key Insights:

  • Laser ablation of melanocytic nevi presents potential risks that require careful consideration.
  • Suggestions are provided for clinicians and patients to determine nevus suitability for laser ablation.
  • Mitigating risks and improving patient outcomes are achievable through informed decision-making.

Outlook:

  • Further research is needed to fully understand and quantify the risks of laser MN ablation.
  • Standardized guidelines for nevus suitability assessment and patient counseling are recommended.
  • Continued evaluation of long-term outcomes and potential complications is essential.

Related Concept Videos